Bio-Path Holdings
  • About Bio-Path
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us

SEC Form 1-Z: Exit Report

https://www.sec.gov/Archives/edgar/data/0001133818/000166357726000050/xsl1-Z_X01/primary_doc.xml

SEC Form-8K: Current Report 5.01 – Changes in Control of Registrant; 5.03 – Amendments to Articles of Incorporation; 7.01 – Regulation FD Disclosure; 8.01 – Other Events

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001133818/000166357726000046/bpth_8k022426.htm

Form 10-Q: Quarterly Report [Section 13 or 15(d)]


Quarterly report [Sections 13 or 15(d)] Open document

Form NT 10-Q: Notification of inability to timely file Form 10-Q or 10-QSB


Notification of inability to timely file Form 10-Q or 10-QSB

Form 8-K: Current report Open document Filing Open filing 5.02 – Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers 8.01 – Other Events

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001133818/000166357725000317/bpth_8k110425.htm

Form 8-K: Current Report Open Document Filing Open filing 5.02 – Departure of Directors or Certain Officers E

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001133818/000166357725000303/bpth_8k102225.htm

Form 10-Q: Quarterly Report [Sections 13 or 15(d)]

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001133818/000155837025011591/bpth-20250630x10q.htm

Form 8-K: Current report Open document Filing Open filing 4.01 – Changes in Registrant’s Certifying Accountant 9.01 – Financial Statements and Exhibits


Current report Open documentFilingOpen filing4.01 – Changes in Registrant’s Certifying Accountant9.01 – Financial Statements and Exhibits

Form 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities


Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities 

Form 8-K: Item 5.02 Departure of Directors or Certain Officers

BPTH_20250624_8-K

Bio-Path Holdings

All Rights Reserved

Office:

625 Stanwix Street
Pittsburgh, PA, 15222

T: (630) 708-0750

logo
  • About Bio-Path
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us